BSC
MRNA icon

Brown Shipley & Co’s Moderna MRNA Stock Holding History

Brown Shipley & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.28K Hold
104
– – ﹤0.01% 74
2026
Q1 		$5.28K Hold
104
– – ﹤0.01% 77
2025
Q4 		$3.07K Hold
104
– – ﹤0.01% 69
2025
Q3 		$2.69K Hold
104
– – ﹤0.01% 62
2025
Q2 		$2.87K Hold
104
– – ﹤0.01% 65
2025
Q1 		$2.95K Hold
104
– – ﹤0.01% 62
2024
Q4 		$4.32K Buy
+104
New +$4.97K ﹤0.01% 64
2024
Q1 		– Sell
-95
Closed -$9.45K – 104
2023
Q4 		$9.45K Hold
95
– – ﹤0.01% 87
2023
Q3 		$9.81K Buy
+95
New +$10.6K 0.01% 87

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Brown Shipley & Co's MRNA Position: Q2 2026 in Review

Brown Shipley & Co held its Moderna (MRNA) position steady in Q2 2026 at 104 shares worth $7.28K. The position accounts for ﹤0.01% of the portfolio, ranked #74.

Brown Shipley & Co first reported a position in MRNA in Q3 2023 and has held it in 9 quarters since. The position peaked at $9.81K in Q3 2023. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Brown Shipley & Co held 104 shares of Moderna worth $7.28K as of Q2 2026.
  • Brown Shipley & Co left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Brown Shipley & Co's portfolio in Q2 2026, its #74 holding.
  • Brown Shipley & Co first reported a position in Moderna in Q3 2023 and has held it in 9 quarters since.
  • Brown Shipley & Co's Moderna position peaked at $9.81K in Q3 2023.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Brown Shipley & Co's 13F filing for Q2 2026, filed 14 Jul 2026.